Biotechnology Services

We’re spending extra on leisure and journey. These 11 shares will soak it up.

Enphase’s ‘good enough’ quarter pushes inventory 12% increased

SolarEdge to put off 16% of its workforce as a part of cost-cutting plan

Sell AstraZeneca, says UBS, which upgrades European rivals together with GSK

GSK to purchase bronchial asthma drug developer for as much as $1.4 billion in pipeline push

Nvidia dives deeper into AI drug growth with Amgen, Recursion partnerships 

Omega Therapeutics inventory greater than doubles on Novo Nordisk weight problems drug analysis pact

Moderna’s inventory soars after Oppenheimer upgrades to purchase

The best-performing inventory of the yr rose practically 10-fold, whereas the 2nd-best averted catastrophe to surge 1,000% in a wild 2023

Enphase Energy to put off 10% of its workforce, citing ‘difficult’ economic system